• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变 TSC2 蛋白在有丝分裂中的非规范功能。

Non-canonical functions of a mutant TSC2 protein in mitotic division.

机构信息

Department of Cell & Developmental Biology, School of Medicine Basic Sciences, Vanderbilt University, Nashville, Tennessee, United States of America.

Rosamund Stone Zander Translational Neuroscience Center, Department of Neurology, Harvard Medical School, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2023 Oct 4;18(10):e0292086. doi: 10.1371/journal.pone.0292086. eCollection 2023.

DOI:10.1371/journal.pone.0292086
PMID:37792789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10550124/
Abstract

Tuberous Sclerosis Complex (TSC) is a debilitating developmental disorder characterized by a variety of clinical manifestations. TSC is caused by mutations in the TSC1 or TSC2 genes, which encode the hamartin/tuberin proteins respectively. These proteins function as a heterodimer that negatively regulates the mechanistic Target of Rapamycin Complex 1 (mTORC1). TSC research has focused on the effects of mTORC1, a critical signaling hub, on regulation of diverse cell processes including metabolism, cell growth, translation, and neurogenesis. However, non-canonical functions of TSC2 are not well studied, and the potential disease-relevant biological mechanisms of mutations affecting these functions are not well understood. We observed aberrant multipolar mitotic division, a novel phenotype, in TSC2 mutant iPSCs. The multipolar phenotype is not meaningfully affected by treatment with the inhibitor rapamycin. We further observed dominant negative activity of the mutant form of TSC2 in producing the multipolar division phenotype. These data expand the knowledge of TSC2 function and pathophysiology which will be highly relevant to future treatments for patients with TSC.

摘要

结节性硬化症(TSC)是一种使人虚弱的发育障碍,其特征是多种临床表现。TSC 是由 TSC1 或 TSC2 基因突变引起的,这两个基因分别编码错构瘤蛋白/结节素蛋白。这些蛋白作为异二聚体起作用,负调控雷帕霉素靶蛋白复合物 1(mTORC1)。TSC 研究集中在 mTORC1(一个关键的信号枢纽)对代谢、细胞生长、翻译和神经发生等多种细胞过程的调节作用。然而,TSC2 的非典型功能尚未得到很好的研究,影响这些功能的突变的潜在疾病相关生物学机制也尚未得到很好的理解。我们在 TSC2 突变的 iPSC 中观察到了异常的多极有丝分裂分裂,这是一种新的表型。多极表型不受雷帕霉素抑制剂治疗的显著影响。我们进一步观察到 TSC2 突变形式的显性负性活性在产生多极分裂表型方面的作用。这些数据扩展了 TSC2 功能和病理生理学的知识,这将对 TSC 患者的未来治疗具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/10550124/8cfd459524b3/pone.0292086.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/10550124/b9e089168cc4/pone.0292086.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/10550124/80b19d26be91/pone.0292086.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/10550124/8cfd459524b3/pone.0292086.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/10550124/b9e089168cc4/pone.0292086.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/10550124/80b19d26be91/pone.0292086.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/10550124/8cfd459524b3/pone.0292086.g003.jpg

相似文献

1
Non-canonical functions of a mutant TSC2 protein in mitotic division.突变 TSC2 蛋白在有丝分裂中的非规范功能。
PLoS One. 2023 Oct 4;18(10):e0292086. doi: 10.1371/journal.pone.0292086. eCollection 2023.
2
Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.雷帕霉素复合物1过度激活导致的6-磷酸果糖-2-激酶(PFKFB3)上调对结节性硬化症中的肿瘤生长至关重要。
IUBMB Life. 2020 May;72(5):965-977. doi: 10.1002/iub.2232. Epub 2020 Jan 20.
3
Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.结节性硬化复合物2(TSC2)N端结构为复合物组装及结节性硬化症发病机制提供了见解。
J Biol Chem. 2016 Sep 16;291(38):20008-20. doi: 10.1074/jbc.M116.732446. Epub 2016 Aug 4.
4
The non-essential TSC complex component TBC1D7 restricts tissue mTORC1 signaling and brain and neuron growth.非必需的 TSC 复合物成分 TBC1D7 限制组织 mTORC1 信号转导以及脑和神经元生长。
Cell Rep. 2022 May 17;39(7):110824. doi: 10.1016/j.celrep.2022.110824.
5
Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish.杂合性 Tsc2 失活增强 p53 突变型斑马鱼的肿瘤发生。
Dis Model Mech. 2013 Jul;6(4):925-33. doi: 10.1242/dmm.011494. Epub 2013 Mar 27.
6
Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy.BI-2536对Polo样激酶1(PLK1)的药理学抑制作用通过诱导凋亡和减弱自噬来降低错构瘤蛋白和结节性硬化蛋白缺陷细胞的活力和存活率。
Cell Cycle. 2015;14(3):399-407. doi: 10.4161/15384101.2014.986394.
7
Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration.结节性硬化复合物蛋白 tuberin 的缺失会导致浦肯野细胞退化。
Neurobiol Dis. 2011 Jul;43(1):113-22. doi: 10.1016/j.nbd.2011.02.014. Epub 2011 Mar 17.
8
Renal disease in tuberous sclerosis complex: pathogenesis and therapy.结节性硬化症相关肾脏疾病:发病机制与治疗。
Nat Rev Nephrol. 2018 Nov;14(11):704-716. doi: 10.1038/s41581-018-0059-6.
9
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.结节性硬化症复合基因产物,即结节蛋白和错构瘤蛋白,通过作为Rheb的GTP酶激活蛋白复合物来控制mTOR信号传导。
Curr Biol. 2003 Aug 5;13(15):1259-68. doi: 10.1016/s0960-9822(03)00506-2.
10
Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.悼念阿尔弗雷德·G·克努森博士:双打击假说、肿瘤抑制基因与结节性硬化症复合体
Cancer Sci. 2017 Jan;108(1):5-11. doi: 10.1111/cas.13116. Epub 2017 Jan 23.

引用本文的文献

1
Dephosphorylation of 4EBP1/2 Induces Prenatal Neural Stem Cell Quiescence.4EBP1/2的去磷酸化诱导产前神经干细胞静止。
bioRxiv. 2023 Feb 15:2023.02.14.528513. doi: 10.1101/2023.02.14.528513.

本文引用的文献

1
The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC).结节性硬化症(TSC)的神经发育发病机制。
Front Neuroanat. 2020 Jul 14;14:39. doi: 10.3389/fnana.2020.00039. eCollection 2020.
2
Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex.丹麦结节性硬化症患者 TSC1 和 TSC2 的突变分析。
Sci Rep. 2020 Jun 18;10(1):9909. doi: 10.1038/s41598-020-66588-4.
3
First comprehensive TSC1/TSC2 mutational analysis in Mexican patients with Tuberous Sclerosis Complex reveals numerous novel pathogenic variants.
首次对墨西哥结节性硬化症患者的 TSC1/TSC2 进行全面突变分析,揭示了许多新的致病性变异。
Sci Rep. 2020 Apr 20;10(1):6589. doi: 10.1038/s41598-020-62759-5.
4
mTOR at the nexus of nutrition, growth, ageing and disease.mTOR 在营养、生长、衰老和疾病的交汇点。
Nat Rev Mol Cell Biol. 2020 Apr;21(4):183-203. doi: 10.1038/s41580-019-0199-y. Epub 2020 Jan 14.
5
Rapalog resistance is associated with mesenchymal-type changes in Tsc2-null cells.雷帕霉素耐药与 Tsc2 基因敲除细胞的间充质样改变有关。
Sci Rep. 2019 Feb 28;9(1):3015. doi: 10.1038/s41598-019-39418-5.
6
Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin.由 TSC 患者来源的浦肯野细胞表现出兴奋性降低和突触缺陷,与 FMRP 水平降低有关,并可被雷帕霉素逆转。
Mol Psychiatry. 2018 Nov;23(11):2167-2183. doi: 10.1038/s41380-018-0018-4. Epub 2018 Feb 15.
7
Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming.杂合性缺失 TSC2 改变了 p53 信号通路和人类干细胞重编程。
Hum Mol Genet. 2017 Dec 1;26(23):4629-4641. doi: 10.1093/hmg/ddx345.
8
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.依维莫司辅助治疗伴结节性硬化症的耐药性局灶性癫痫发作(EXIST-3):一项 3 期、随机、双盲、安慰剂对照研究。
Lancet. 2016 Oct 29;388(10056):2153-2163. doi: 10.1016/S0140-6736(16)31419-2. Epub 2016 Sep 6.
9
Plk1 relieves centriole block to reduplication by promoting daughter centriole maturation.Plk1通过促进子代中心粒成熟来解除中心粒复制阻滞。
Nat Commun. 2015 Aug 21;6:8077. doi: 10.1038/ncomms9077.
10
mTOR complexes in neurodevelopmental and neuropsychiatric disorders.mTOR 复合物在神经发育和神经精神疾病中的作用。
Nat Neurosci. 2013 Nov;16(11):1537-43. doi: 10.1038/nn.3546. Epub 2013 Oct 28.